Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 17,345 shares at $183.28 ($3.3M) on 2021-06-17, disclosed to the SEC on 2021-06-17.
Open-market sale of $3.3M NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $183.53 | 1 | $184 | 0.0% |
| 2 | $186.45 | 37 | $7K | 0.2% |
| 3 | $187.04 | 1,810 | $339K | 10.4% |
| 4 | $187.04 | 1,810 | $339K | 10.4% |
| 5 | $187.07 | 154 | $29K | 0.9% |
| 6 | $187.07 | 2,254 |
| $422K |
| 12.9% |
| 7 | $187.86 | 8 | $2K | 0.0% |
| 8 | $189.62 | 53 | $10K | 0.3% |
| 9 | $190.31 | 1,387 | $264K | 8.1% |
| 10 | $190.31 | 1,387 | $264K | 8.1% |
| 11 | $191.25 | 261 | $50K | 1.5% |
| 12 | $192.14 | 121 | $23K | 0.7% |
| 13 | $193.50 | 557 | $108K | 3.3% |
| 14 | $193.50 | 557 | $108K | 3.3% |
| 15 | $194.35 | 335 | $65K | 2.0% |
| 16 | $194.35 | 335 | $65K | 2.0% |
| 17 | $195.24 | 188 | $37K | 1.1% |
| 18 | $196.65 | 310 | $61K | 1.9% |
| 19 | $196.65 | 310 | $61K | 1.9% |
| 20 | $198.39 | 200 | $40K | 1.2% |
| 21 | $200.00 | 448 | $90K | 2.7% |
| 22 | $183.28 | 2,411 | $442K | 13.5% |
| 23 | $183.28 | 2,411 | $442K | 13.5% |
| Total | $188.22 avg | 17,345 | $3.3M | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |